Search results
Ozempic and 19 other drugs have 'junk' patents, the FTC says in a new challenge
Quartz· 10 hours agoNovo Nordisk’s popular diabetes drug Ozempic is among the drugs with patents that are being...
Ozempic: an expert separates fact from fiction
The Telegraph via Yahoo News· 22 hours agoThree years ago injecting yourself skinny seemed positively futuristic. Now, everyone from Oprah Winfrey and Elon Musk to your local hairdresser are...
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
WKMG ClickOrlando· 13 hours agoFederal regulators are challenging patents on 20 brand-name drugs, including the blockbuster...
FTC Targets ‘Junk’ Patent Listings on Ozempic and Other Drugs
The Wall Street Journal· 8 hours agoThe crackdown is the latest assault against what the agency regards as drugmakers’ patent ploys...
FTC cracks down on drugmaker patents, including Novo's Ozempic; analysts weigh in By Investing.com
Investing.com· 10 hours agoOn Tuesday, the Federal Trade Commission (FTC) said it is challenging hundreds of what it calls...
Some of the popular weight loss drug Wegovy is back on shelves after a shortage, the FDA says
Quartz· 1 day agoA dose of Wegovy’s highly-coveted weight loss drug is no longer in limited supply, according to Food...
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic
CNBC· 12 hours agoThe Federal Trade Commission on Tuesday said it is challenging hundreds of alleged "junk" patents...
Novo’s Blockbuster Ozempic Among FTC’s Latest Patent Targets
Bloomberg Law· 13 hours agoOzempic and Victoza are among 20 branded drugs the Federal Trade Commission is targeting as it challenges more than 300 “junk patent listings” in the FDA’s registry of approved ...